# A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

> **NCT05074992** · PHASE2 · TERMINATED · sponsor: **University College, London** · enrollment: 1 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Ipilimumab

## Key facts

- **NCT ID:** NCT05074992
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-24
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Support withdrawn from drug company supplying IMP
- **Last updated:** 2024-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074992, "A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05074992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*